Product Information
- Cyclosiversioside F(3β,6α,16β,24R)-20,24-Epoxy-16,26-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl β-D-glucopyranoside
- (3beta,6alpha,9beta,16beta,20R,24S)-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-threo-hexopyranoside
- (3β,6α,16β,24R)-20,24-Epoxy-16,25-dihydroxy-3-(β-<span class="text-smallcaps">D</smallcap>-xylopyranosyloxy)-9,19-cyclolanostan-6-yl β-<smallcap>D</span>-glucopyranoside
- 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
- 9,19-Cyclolanostane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
- Astragalin A
- Astramembrannin I
- beta-D-Glucopyranoside, (3beta,6alpha,16beta,24R)-20,24-
- cyclolanostan-6-yl
- epoxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-
- See more synonyms
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,6α,16β,24R)-20,24-epoxy-16,25-dihydroxy-3-(β-<smallcap>D</span>-xylopyranosyloxy)-9,19-cyclolanostan-6-yl
Astragaloside IV is a natural product found in the root of Astragalus membranaceus. It has been shown to have significant up-regulation in response to brain injury and to protect neurons from injury. Astragaloside IV also has anti-inflammatory effects and may be a potential therapeutic agent for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. This compound binds to the NF-κB pathway, which prevents activation of pro-inflammatory genes, including Bcl-2 protein, resulting in reduced nitrate reductase activity and decreased kidney injury.
Chemical properties
Technical inquiry about: 3D-MA08288 Astragaloside IV
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
